1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
65D0A0F85965E6B4365257C8D001CEF5F
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/creating-and-maintaining-strategic-kol-management-and-engagement-system
18
19
2018.97.14.91
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services » »

Creating and Maintaining a Strategic KOL Management and Engagement System

ID: POP-253


Features:

9 Info Graphics

20+ Data Graphics

100+ Metrics

19 Narratives


Pages: 56


Published: Pre-2019


Delivery Format: Shipped


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
Key Opinion Leaders (KOLs) are recognized as one of the most effective avenues for building awareness in medical and scientific communities. As biopharma organizations reconsider their strategic approach to TL engagement, they are seeking an evidence-based understanding of current and evolving approaches to creating and maintaining an integrated, strategically-focused TL management system.


Best Practices, LLC conducted this in-depth study to address the following key areas:

  • Identify the most common and favored organizational structure for strategic TL management and engagement
  • Understand the current state of TL management practices in the pharmaceutical industry
  • Determine how TL management practices are evolving
  • Identify innovative practices that are driving TL management success at other organizations
Industries Profiled:
Health Care; Pharmaceutical; Biotech; Education; Science; Medical Device; Biopharmaceutical; Clinical Research; Laboratories; Medical; Manufacturing


Companies Profiled:
Abbott Nutrition; Marcyrl; Antibiotice; Abbvie; A.P. Pharma; Amgen; Janssen Biotech; Inc.; Astellas; Reliance Institute of Life Sciences; Baxter International; Sanofi Renal; Biogen Idec; TauRx Therapeutics; Boehringer Ingelheim; Crescendo Bioscience; Cubist Pharmaceuticals; Eisai; Intermune; Janssen; Jazz Pharmaceuticals; Mallinckrodt; Medtronic; Merck; MSD; Onyx Pharmaceuticals; Pierre Fabre Medicament; ProStrakan; Roche; Sanofi; Servier; Shire

Study Snapshot

Thirty-four thought-leader management leaders from 29 biopharma and device organizations participated in the field survey, and we interviewed 4 for in-depth insights.

Key Findings

Strategic TL Management Structure: Most respondents believe a decentralized thought-leader management structure is not optimal, though almost 40% use a decentralized system now. Most view a hybrid or centralized structure (48 and 38%, respectively) as optimal for modern Thought Leader engagement.

  • Medical Affairs Guides TL Engagement/ Strategy: 80% of companies said Medical Affairs oversees thought-leader engagement and strategy, but their structures do not support this. Only 31% say that Medical Affairs handles the administration of such programs. This represents a potential gap where priorities can become misaligned.
  • Coordination of Strategic KOL Management and Engagement Activities: According to benchmark partners, effective communication between all stakeholders is the most effective way for coordinating KOL management across different functions.
  • Most Valued KOL Activities: 87% of benchmark participants regarded Advisory boards as the most valued KOL activity and 77% consider scientific presentations to be valuable.
  • Key Elements For Strategic KOL Management: Benchmark partners cited the key elements for strategic KOL management: System/internal platform, a coordinator or primary point of contact and a cross-functional team in each TA or BU that shares KOL interaction information with senior leadership.
Table of Contents

Executive Summary
  • Research Overview
  • Participating Companies
  • Key Findings & Insights
Universe of Learning: Key Demographics of Participating Companies ………………6
Structuring Strategic Thought Leader Management and Engagement …………….…9
Administering Strategic Thought Leader Management and Engagement……………15
Coordinating and Communicating Strategic Thought Leader Management and Engagement….22
Aligning Software Tools to Support Strategic Thought Leader Management and Engagement…..30
Identifying and Engaging Thought Leaders………………………………………………..35
Measuring Strategic Thought Leader Management and Engagement Success……..42
Staffing Strategic Thought Leader Management and Engagement……………………45
Looking Forward: Success Factors for Strategic TL Management  & Engagement..51
About Best Practices, LLC

Sample List of Charts & Exhibits

Job level of the participants
  • Participant's fucntional representation
  • Structure of KOL management and engagement system in the organization
  • Primary oversight function for strategic KOL management and engagement system
  • Does organizations have separate KOL roles for strategy and relationships
  • Job level for oversight role of strategic KOL management and engagement
  • How organization's administer its strategic KOL management and engagement system?
  • Coordination of strategic KOL management and engagement activities
  • Software programs/products/systems to build and manage KOL relationships
  • System for global line of sight on all KOL activities
  • Importance of strategic approaches to identifying and managing KOLs
  • Importance of KOL services
  • Most valued KOL activities
  • Evaluating success of strategic KOL management and engagement
  • Feedback from KOLs on company interactions
  • Top KOL values based on feedback
  • Value of strategic KOL management and engagement work
  • Strategic KOL management and engagement FTE
  • Strategic KOL management and engagement career pathway
  • Strategic KOL management and engagement career ladder steps